Left ventricular assist devices (LVADs) are an increasingly used strategy for the
management of patients with advanced heart failure with reduced ejection fraction. Although …

Advanced heart failure (A-HF) is characterized by progressive symptoms of heart failure
despite optimal therapy. In patients with A-HF, ventricular arrhythmias (VAs) are common …

CO-CHAIRS: Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia
Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of …

This international consensus statement of the European Heart Rhythm Association (EHRA),
Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society is intended to provide …

The implantable cardioverter defibrillator (ICD) has emerged as an important treatment
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …

Objectives: This study sought to evaluate the prevalence and significance of ventricular
arrhythmia (VA) and the role of an implantable cardioverter-defibrillator (ICD) in patients …

Mechanical circulatory assist devices are now commonly used in the treatment of severe
heart failure as bridges to cardiac transplant, as destination therapy for patients who are not …

The incidence of ventricular tachycardia (VT) or ventricular fibrillation (VF) in patients
supported with a continuous-flow left ventricular assist device (LVAD) has not been …

Heart failure (HF) is a major cause of morbidity and mortality with more than 5.1 million
individuals affected in the USA. Ventricular tachyarrhythmias (VAs) including ventricular …

Objectives: This study aimed to evaluate the incidence, clinical impact, and predictors of late
ventricular arrhythmias (VAs) in left ventricular assist device (LVAD) recipients aiming to …